Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
26 search results for:

Basal cell carcinoma 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 21-06-2022 | Basal cell carcinoma | Adis Journal Club | Article
    Oncology and Therapy

    Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management

    Desai Abstract Basal cell carcinoma (BCC) is the most common, accounting for 80–90% of skin cancers.

  2. 28-01-2022 | Basal cell carcinoma | Adis Journal Club | Article
    Advances in Therapy

    New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma

    Hedgehog signaling pathway has an important role in the development of basal cell carcinoma, and its inhibition is the key to new treatment options available for the treatment of locally advanced and metastatic basal cell carcinoma.

  3. 29-04-2016 | Non-melanoma skin cancer | Article

    Basal cell carcinoma

    Perera E, Sinclair E. In: Dermatological Cryosurgery and Cryotherapy . Edited by Abramovits W et al. London: Springer-Verlag London, 2016. doi:10.1007/978-1-4471-6765-5_130

  4. 05-02-2016 | Non-melanoma skin cancer | Article

    Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face

    Feller L. et al. Head Face Med 2016; 12: 11. doi:10.1186/s13005-016-0106-0

  5. 29-04-2016 | Non-melanoma skin cancer | Article

    Basal cell carcinoma of the eye area

    Limmer BL. In: Dermatological Cryosurgery and Cryotherapy . Edited by Abramovits W et al. London: Springer-Verlag London, 2016. doi:10.1007/978-1-4471-6765-5_58

  6. 21-03-2017 | Basal cell carcinoma | Article

    Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

    Evan J et al. J Immunotherapy Cancer 2017; 5: 23. doi:10.1186/s40425-017-0228-3

  7. 20-02-2017 | Non-melanoma skin cancer | Article

    Giant adenoid basal cell carcinoma of the scalp with intracranial involvement—successful management strategies for a rare entity

    Ascha M et al. Eur J Plast Surg 2017. doi:10.1007/s00238-017-1297-8

  8. 01-09-2016 | Non-melanoma skin cancer | Article

    Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials

    Chang ALS et al. Orphanet J Rare Dis 2016; 11: 120. doi:10.1186/s13023-016-0506-z

  9. 22-06-2013 | Non-melanoma skin cancer | Article

    Basal Cell Carcinoma: Molecular and Pathological Features

    Franco et al provide a review of the molecular and pathological features of basal cell carcinoma and describe the progressive increase in its incidence during the past decades. Franco R et al. In: Skin Cancer. Edited by Baldi A et al. Springer Science+Business Media New York, 2014. doi:10.1007/978-1-4614-7357-2_5

  10. 03-02-2015 | Basal cell carcinoma | Article

    Management of high-risk and advanced basal cell carcinoma

    An expert review of the management recommendations for high-risk and advanced basal cell carcinoma including surgical excision, Mohs micrographic surgery, radiotherapy, and novel agents in development. Puig S |& Berrocal A. Clin Transl Oncol 2015; 17: 497–503. doi:10.1007/s12094-014-1272-9

  11. 04-08-2016 | Non-melanoma skin cancer | Article

    The invisible basal cell carcinoma: how reflectance confocal microscopy improves the diagnostic accuracy of clinically unclear facial macules and papules

    Ruini C et al.  Lasers Med Sci 2016; 31: 1727–1732. doi:10.1007/s10103-016-2043-3

  12. 04-11-2015 | Non-melanoma skin cancer | Case report | Article

    Case report: Imiquimod 5% as adjuvant therapy for incompletely excised infiltrative nodular basal cell carcinoma and dermoscopy to monitor treatment response

    Roldán-Marín R, Toussaint-Caire S. Dermatol Ther (Heidelb) 2015;5:265–272. doi:10.1007/s13555-015-0088-z

  13. 14-03-2023 | EMA | News | Article
    approvalsWatch

    EMA recommends extension to cemiplimab indication

    The regulatory agency previously supported  the use of the PD-1 inhibitor as monotherapy for the first-line treatment of patients with PD-L1 expression levels of at least 50%, and the agent is also approved for the treatment of basal cell carcinoma and cervical cancer. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2023 Springer Healthcare Ltd, part of the Springer Nature Group

    Author:
    Shreeya Nanda
  14. 15-10-2021 | Treatment | Adis Journal Club | Article
    Advances in Therapy

    Non-Surgical Treatments for Keratinocyte Carcinomas

    In recent decades, the incidence of keratinocyte carcinomas, which include basal cell carcinoma and cutaneous squamous cell carcinoma, has been steadily increasing globally (Rogers et al. in JAMA Dermatol 151(10):1081–1086. 

  15. 05-01-2018 | Non-melanoma skin cancer | News | Article

    Topical fluorouracil may have role in cutaneous SCC chemoprevention

    A single course of topical fluorouracil can prevent the occurrence of cutaneous squamous cell carcinoma requiring surgery in the first year after use, trial results suggest.

    Published in:
    JAMA Dermatol 2018; Advance online publication
  16. 14-04-2016 | Non-melanoma skin cancer | Article

    Diagnosis and management of hereditary basal cell skin cancer

    Shanley S, McCormack C. In: Rare Hereditary Cancers . Edited by S Shanley, C McCormack. Switzerland: Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-29998-3_11

  17. 16-11-2016 | Triple-negative breast cancer | Article

    Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants

    Among the basal-like subtypes, the basal-like 1 subset was found to be enriched in cell division and DNA damage response pathways, whereas the basal-like 2 group displayed an association with growth factor signaling and myoepithelial marker expression.

    Author:
    Fresia Pareja, Felipe C Geyer, Caterina Marchiò, Kathleen A Burke, Britta Weigelt, Jorge S Reis-Filho
  18. 16-08-2017 | Melanoma | News | Article

    Final BRIM-3 data confirm vemurafenib survival benefit over dacarbazine

    These included squamous cell carcinoma of the skin (20 vs <1%), keratoacanthoma (11 vs 1%), basal cell carcinoma (3 vs <1%), and malignant melanoma (2 vs 0%).

    Published in:
    Ann Oncol 2017; Advance online publication
  19. 02-03-2017 | Liquid biopsy | Review | Article

    Integrating liquid biopsies into the management of cancer

    Notably, however, Wang and colleagues 8 analysed DNA in saliva for potential tumour biomarkers in 93 patients with head and neck squamous-cell carcinoma (HNSCC).

    Author:
    Giulia Siravegna, Silvia Marsoni, Salvatore Siena, Alberto Bardelli
  20. 17-05-2016 | Triple-negative breast cancer | Article

    Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease

    Other subtypes with unique phenotypes — including adenoid cystic carcinoma 14, 17 , adenosquamous carcinoma and fibromatosis-like spindle-cell metaplastic carcinomas — are rare (<1%) and less aggressive, and typically only capable of local recurrence, a feature that should be considered when planning adjuvant treatment 17 .

    Author:
    Giampaolo Bianchini, Justin M. Balko, Ingrid A. Mayer, Melinda E. Sanders, Luca Gianni

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.